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Abstract
Background: High coverage and attendance is essential for cervical cancer screening success. We investigated
whether the previous positive experiences on increasing screening attendance by self-sampling in Finland are
sampler device dependent.
Methods: All women identified to cervical cancer screening in 2013 in 28 Finnish municipalities were
randomised to receive a lavage- (n = 6030) or a brush type of self-sampling device (n = 6045) in case of
non-attendance after two invitation letters. Seven hundred seventy non-attending women in the lavage
device group and 734 in the brush group received the self-sampling offer. Women’s experiences were
enquired with an enclosed questionnaire.
Results: Total attendance in the lavage group increased from 71.0 to 77.7 % by reminder letters and further
to 80.5 % by self-sampling. Respective increase in the brush group was from 72.2 to 78.6 % and then to
81.5 %. The participation by self-sampling was 21.7 % (95 % CI 18.8–24.6) in the lavage group and 23.8 %
(95 % CI 20.8–26.9) in the brush group. Women’s self-sampling experiences were mainly positive and the
sampler devices were equally well accepted by the women.
Conclusion: Our study shows that the lavage device and brush device perform similarly in terms of uptake
by non-attending women and user comfort. If self-sampling is integrated to the routine screening program in
Finland, either of the devices can be chosen without the fear of losing participants due to a less acceptable
device.
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Background
A maximal attendance and coverage of screening is cru-
cial to further reduce the incidence and mortality of cer-
vical cancer. In Finland, the attendance rate in the
screening program is currently approximately 70 % [1]
and a substantial portion of cervical cancers diagnosed
among women in screening ages (30–60 years of age) in
Finland are detected among women not attending
screening [2–4]. The use of pre-assigned appointment
times in invitations and reminder letters increase screen-
ing attendance by 6.6–9.4 % [5–9]. Offering high risk
human papillomavirus (hrHPV) testing on self-taken
samples (self-sampling) to the non-attendees of the rou-
tine screening helps to overcome practical and emo-
tional barriers to screening and has the potential to
increase screening attendance [5, 9–15]. However, only
one study thus far has compared the participation and
acceptability of different self-sampling devices in an ac-
tual screening setting [16]. Based on the previous result
the brush device is non-inferior to the lavage device in
these aspects [16].
The main aim of this study was to compare the effects
of a lavage- and a brush-type self-sampling device on
screening attendance within the routine screening pro-
gram in Finland. We also compared women’s perceptions* Correspondence: liisa.karjalainen@helsinki.fi1Mass Screening Registry, Finnish Cancer Registry, Unioninkatu 22, FI-00130,
Helsinki, Finland
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and experiences of the self-sampling procedure with
these devices.
Methods
In the Finnish screening program all women aged 30–
60 years of age are invited by personal invitations in 5-
year intervals. In some municipalities also women aged
25 and/or 65-years of age are included. Primary screen-
ing modality in most municipalities is Pap-testing, some
use primary HPV-testing.
This study was conducted as a part of routine screen-
ing in 28 Finnish municipalities in 2013, including both
urban and rural areas. The screening visits were ar-
ranged locally but all participating municipalities used
the same screening laboratory of the Cancer Society of
Finland for the analysis of the samples. All participating
municipalities used Pap-testing as a screening modality.
Originally 32 municipalities (12,555 women) were to
take part in the study. Based on previous studies on the
use of reminder letters and self-sampling as a second re-
minder in Finland, we estimated that participation rate
after two invitation letters would be 80 and 20 % of
women who were offered the lavage-type self-sampling
test would participate [5, 6, 17]. This would leave 2511
women (1256 per arm) to be invited by self-sampling
and would allow for us to detect a 4.8 % difference in
participation rates between self-sampling methods (2
sided, power = 0.8, alpha = 0.05). Later, four municipal-
ities dropped out of the study due to a lack of local re-
sources. Self-sampling groups were also smaller than
expected due to missing invitations and e.g., emigration
(Fig. 1).
The exact flow of women in the invitation protocol in
each research arm is shown in Fig. 1. All women identi-
fied for screening in the 28 participating municipalities
in 2013 were included in the study. Overall the cohort
consisted of 12,075 women who were, upon identifica-
tion for screening, randomised to receive a lavage-based
(6030) or a brush-based self-sampling device (6045) in
case of non-attendance. Women were invited to screen-
ing by a personal letter. Non-attendees after the primary
screening invitation received a second invitation (re-
minder letter) within the same year - with the exception
of those women who had declined from screening
Fig. 1 The flow of women in the invitation protocol. a Includes 324 women in lavage-device arm and 329 women in the brush-device arm who
attended before the invitation was sent or made an appointment for screening (e.g., by phone) and thus received no invitation letter. b Women
received an information letter about the up-coming self-sampling test with an opt-out option. c Out of all women to whom self-sampling was
offered to
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altogether when cancelling the given appointment (a fea-
ture of the program used when sending out the invita-
tions). Both invitation letters included a pre-assigned
appointment time that could be changed by telephone
or over the internet. After the two invitation letters, the
non-attendees were extracted from the screening data-
base. Only women still living in the original inviting mu-
nicipality, with address information available, were
included in self-sampling intervention, and again women
who had declined screening altogether while cancelling
the given screening appointment were excluded (Fig. 1).
There were a few errors in the invitation protocol. three
hundred twenty-six women (159 in the lavage device
arm and 167 in the brush device arm) did not receive a
reminder letter despite of their non-attendance and two
women in the brush device arm were not offered self-
sampling test in error (Fig. 1).
Prior to sending out the sampler device, the self-
sampling possibility was introduced with a letter with an
opt-out option offering women a possibility the decline
the self-sampling device beforehand. Questionnaires sur-
veying the women’s experience of sample taking, general
attitudes towards self-sampling and previous screening
history were sent together with the sampler devices. The
women were unaware of the randomisation and the use
of two different sampler devices in this study.
The material was sent in the women’s mother tongue
(Finnish or Swedish; the two official languages in
Finland). Women with mother tongue other than
Finnish or Swedish received the material in Finnish with
the option to order the material in English. All self-
sampling related material was organized centrally by the
Mass Screening Registry.
The screening data from the mass screening register
was combined to data from Statistics Finland to clarify
socio-demographic factors related to the screening par-
ticipation: mother tongue, education level, marital status
and type of home municipality. Education level is re-
corded in Statistics Finland for those who have com-
pleted the lower secondary education. For the purposes
of this study we divided the education into three levels:
primary (including primary education, currently 9 years
in Finland and, due to the registration protocol of Statis-
tics Finland, those with missing education level informa-
tion), secondary (including lower and upper secondary
education) and tertiary (including lower and upper ter-
tiary education and doctoral degree or equivalent). Miss-
ing information on education level was updated from
the questionnaire answers when possible. The mother
tongue was divided into two groups: ‘Finnish or Swedish’,
and ‘other’. Women with Finnish or Swedish as mother
tongue were combined into one group to avoid too
small groups, as they received the study related mate-
rials in their own mother tongue and no significant
differences in screening behavior have been reported be-
tween these groups in previous studies [5, 6, 17]. Marital
status was classified into four categories: unmarried,
married or widowed, divorced and unknown. Married
and widowed women were grouped together to avoid
too small groups and because of previously reported
similar screening behavior [17]. Statistics Finland di-
vides municipalities into three types – urban, semi-
urban and rural – and the same classification was used
in this study. With regard to age, the study cohort was
divided into 10-year age groups: 30–39 (including also
175 women aged under 30 years), 40–49, 50–59 and
60–69 years of age.
Self-sampling tests and HPV-analysis
Sample-taking at home was performed by a lavage-
based device (Delphi Screener, Delphi Bioscience BV,
Sherpenzeel, The Netherlands) or a brush-based device
(Evalyn Brush, Rovers medical devices BV, Oss, The
Netherlands).
The Delphi Screener produces a lavage-sample by rins-
ing the cervix and upper vagina with saline. Saline is re-
leased by pressing a plunger of the device and flows
back into the device when the plunger is released. The
Evalyn Brush produces a dry sample by collecting cer-
vical and upper vaginal endothelial cells when the brush
is rotated in the upper vagina. The brush device is
inserted in the vagina up to its wings, the brush is
pushed out from the casing by pressing a plunger and
rotated five times [16, 18]. In the laboratory, the cell
sample was extracted from the brush by adding buffered
saline.
The self-taken samples were analysed using a Hybrid
Capture 2 (HC2) assay which detects 13 most common
hrHPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58,
59, 68) [19]. Only samples producing a visible cell pellet
after centrifugation at 1500 rpm were considered ad-
equate. Of the originally returned 166 lavage-type sam-
ples one (0.6 %) and of the 170 brush-type samples four
(2.4 %) did not fulfill this criteria (the difference not be-
ing statistically significant). The women in question re-
ceived a new device of the same type and the one
woman in the lavage device group and three women in
the brush device group returned a new adequate sample.
In the end 166 lavage-type samples and 169 brush-type
samples fulfilled the criteria of an adequate sample and
were included in this study. One woman in the lavage
device and six women in the brush device group chose
to attend screening by Pap smear after receiving the self-
sampling kit. They are included in the self-sampling par-
ticipants by intention-to-treat.
Women were notified of their test result by a letter.
Women with a hrHPV-positive result in self-taken sam-
ple were either invited for a Pap smear (women <40-
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years old in 24 municipalities and all women in four mu-
nicipalities) and referred to a colposcopy in case of a
cytological result of low grade squamous cell lesion
(LSIL) or more severe, or repeat atypical squamous cells
of unknown significance (ASC-US); or referred directly
to a colposcopy (women >40-years old in 24 out of 28
municipalities) [20].
Questionnaire study
In total 1284 questionnaires (658 with the lavage-device
and 626 with the brush-device) were sent with the self-
sampling kits. The questionnaire was developed based
on previous pilot studies and previous literature [15, 21–
24]. All questions were presented to an external group
of women to ensure clarity. Women gave their written
consent to link their answers to the screening data.
Women’s experience on self-sampling was measured
using a 16 item survey consisting of 13 questions on
sample taking procedure and attitudes towards self-
sampling and three on the clarity of the user instruc-
tions. A space for open feedback was also provided. Re-
sponses to the items were on a five point Likert-type
scale from “fully agree” to “fully disagree” and a “cannot
say” as options. For the analysis some of the responses
were reversed from the original so that “totally agree”
would present the most positive experience and maximal
acceptability for each of the items. To avoid small re-
sponse frequencies the answers were grouped into three
categories “agree” (fully or somewhat agree), “neither
agree nor disagree” and “disagree” (fully or somewhat
disagree) for the comparison of the experiences with the
sampler devices. Also women’s preferences of the future
screening method (self-taken vs. clinician taken test)
were enquired.
As opportunistic Pap tests are not registered in any
joint database in Finland, the effect on overall screening
coverage (including also opportunistic testing) was esti-
mated using data on previous screening history collected
with the questionnaire. Women were considered under-
screened if they had no previous Pap smears within
5 years.
Statistical methods
The results were analyzed using Stata 12.1. Age-, mother
tongue-, education level-, marital status- and municipal-
ity type adjusted relative risks (RRs) and 95 % confidence
intervals (CI) for participation by self-sampling were es-
timated using Poisson regression. Age-, mother tongue-,
education level-, marital status- and municipality type
adjusted RRs and CIs for the total attendance and for
self-sampling participation by brush-device compared to
the lavage-device were estimated with logbinomial re-
gression. Student’s paired t test was applied to test the
increase in total participation by reminder letters and
self-sampling in both groups, and Fisher’s exact test to
test the statistical significance of the difference in the
user experiences between the self-sampling devices.
Ethics statement
The study was approved by the Ethical committee of the
Hospital District of Helsinki and Uusimaa (79/13/03/03/
2011) and National Institute for Health and Welfare
(THL/1465/6.02.00/2013).
Results
Participation by self-sampling
In the lavage group, 167 out of 770 women (21.7 %,
95 % CI 18.8–24.6), and in the brush group, 175 out of
734 women (23.8 %, 95 % CI 20.8–26.9) participated in
screening (Table 1).
By age, the overall self-sampling participation rate (i.e.,
with both sampler devices together) was highest among
women aged 40–49 and 50–59 years (Table 1). With re-
gard to education level, the participation rate was lowest
among women with only primary education and in-
creased significantly with increasing education level. By
mother tongue, the crude overall participation rate was
slightly higher among Finnish or Swedish speaking
women than among women with a mother tongue other
than these two, but the difference was not statistically
significant in the adjusted model. Further, the difference
was seen only in the brush group. The crude participa-
tion rates were also higher among married and widowed
women, and in semi-urban and rural municipalities, but
these differences were not significant in the adjusted
model.
Table 2 shows the adjusted relative risk of participation
with the brush device in comparison to the lavage de-
vice. The participation rate was slightly higher with the
brush device in all socio-demographic groups, apart
from the oldest age group and women with mother
tongue other than Finnish or Swedish, but the differ-
ences were non-significant.
Increase in total screening attendance
The participation rate after the primary invitation among
all women identified for screening was 71.0 % (95 % CI
69.8–72.1) in the lavage group and 72.2 % (95 % CI
71.1–73.3) in the brush group. The reminder letters in-
creased the attendance to 77.7 % (95 % CI 76.7–78.8)
and to 78.6 % (95 % CI 77.6–79.7), respectively. After
self-sampling the total attendance reached levels of
80.5 % (95 % CI 79.5–81.5) in the lavage group and
81.5 % (95 % CI 80.5–82.5) in the brush group (Fig. 2).
No significant differences in the total attendance rates in
different socio-demographic groups were observed be-
tween the lavage and brush group (data not shown).
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Effects on screening coverage
Of those non-attendees who participated in screening
with a self-taken sample, 64 % (65 % in the lavage group
and 64 % in the brush group) reported a Pap smear in
the preceding screening interval, i.e., <5 years ago (in-
cluding also opportunistic screening). Approximately
20 % (24 % in the lavage group and 17 % in the brush
group) reported a previous Pap smear over 5 years ago
or never and could thus be considered truly under-
screened. Only these under-screened self-sampling par-
ticipants demonstratively increased the overall screening
coverage. Approximately 15 % (11 % in the lavage group
and 19 % in the brush group) did not answer the ques-
tion in the questionnaire and their screening history is
thus not known.
Women’s experience of self-sampling
Response rates to the questionnaire among the self-
sampling participants were 99 % (164/166) in the lavage
group and 98 % (165/169) in the brush group. Figure 3
shows women’s responses to the statements addressing
their experience on self-sampling. Self-sampling was
regarded as easy by 97 % (154/159) of the lavage device
users and by 96 % (149/156) of the brush device users
who responded to the question (fully or somewhat agree
to the statement). Discomfort was reported by 9 % (13/
145) by the lavage device users and 10 % (16/153) by the
brush device users and pain by 3 % (4/146) and 4 % (6/
155), respectively. Feelings of insecurity during sample
taking were reported by 21 % (31/145) in the lavage
group and 23 % (36/154) in the brush group. In the open
answers the most commonly reported problem with the
brush device was the concern about the device being
inserted in the correct depth for sample taking, and not
hearing the clicks when rotating the brush and thus not
knowing the number of rotations, but a clear majority
did not specify what caused them to feel insecure. The
same problems were also reported by the brush users
who did not report insecurity. Considering all lavage
users who rated their device, the reported problems were
related to the plunger of the device not releasing prop-
erly, fluid leaking out during sample taking, the volume
of the collected sample seeming small and difficulties
with the closing strip of the return envelope. The same
Table 1 The mutually adjusted participation rates after self-sampling offer
Lavage-device Brush device Total Mutually adjusted total attendance after self-sampling invitation
Invited Attendeda Invited Attendeda Invited Attendeda RR 95 % CI
n n % n n % n n %
Age groups
30–39 270 48 17,8 277 54 19,5 547 102 18,6 1
40–49 195 48 24,6 170 47 27,6 365 95 26,0 1,34 1,01–1,78
50–59 193 48 24,9 204 62 30,4 397 110 27,7 1,45 1,10–1,91
60–69 112 23 20,5 83 12 14,5 195 35 17,9 1,03 0,69–1,52
Mother tongue
Finnish/Swedish 742 161 21,7 700 169 24,1 1442 330 22,9 1
Other 28 6 21,4 34 6 17,6 62 12 19,4 1,1 0,61–1,95
Education
Primary 101 8 7,9 105 12 11,4 206 20 9,7 1
Secondary 341 74 21,7 352 82 23,3 693 156 22,5 2,26 1,41–3,61
Tertiary 328 85 25,9 277 81 29,2 605 166 27,4 2,74 1,71–4,38
Marital status
Unmarried 259 52 20,1 247 54 21,9 506 106 20,9 1
Married/Widowed 411 96 23,4 365 95 26,0 776 191 24,6 1,05 0,82–1,34
Divorced 96 19 19,8 114 26 22,8 210 45 21,4 0,98 0,69–1,40
Unknown 4 0 0,0 8 0 0,0 12 0 0,0 0
Municipality type
Urban 405 84 20,7 386 88 22,8 791 172 21,7 1
Semi-urban 196 44 22,4 177 46 26,0 373 90 24,1 1,12 0,87–1,45
Rural 169 39 23,1 171 41 24,0 340 80 23,5 1,14 0,88–1,49
Total 770 167 21,7 734 175 23,8 1504 342 22,7
aIncluding one woman in the lavage group and six women in the brush group that attended by Pap smear after self-sampling offer
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problems came up among the lavage users who reported
insecurity, although most women did not specify the
reasons for their insecurity. In both groups several
women requested for instructions on how long the sam-
ple survives unaffected in a mailbox in the arctic winter
conditions.
In both groups 93 % (136/147 in the lavage group and
140/150 in the brush group) of the responders felt
confident that the sample was taken successfully. In the
lavage group 90 % (135/150) of the responders and in
the brush group 85 % (126/149) fully or somewhat
agreed that they trust the test results from the self-
sampling test. These minor differences in women’s expe-
riences between the samplers among all self-sampling at-
tendees were not statistically significant.
Of the under-screened self-sampling participants (re-
ported last smear >5 years ago or never) 67 women
rated their self-sampling experience, 39 in the lavage
group and 28 in the brush group. Among these women
sample-taking was considered easy (100 % vs. 83 %, p =
0.019) and easier than expected (100 vs. 75 %, p = 0.003)
more often with the lavage device and feelings of inse-
curity (6 vs. 9 %, p = 0.019) and pain (0 % vs 8 %, p =
0.03) during sample-taking were reported more often
with the brush device (Table 3).
Preference of future screening method
Women were asked which screening method they would
prefer in future, self-sampling or traditional clinic based
screening. fifty-eight percent (of those who gave answer
to the question; 94/163) of women who participated with
the lavage device and 66 % (105/159) of women who
participated with the brush device would prefer self-
sampling in the future. 13 and 7 %, respectively would
prefer traditional screening in the future. 28 and 27 %,
respectively, had no preference.
Self-sampling test results
7.2 % (12/166) of the returned lavage-samples and 5.9 %
(10/169) of the brush-samples were hrHPV-positive by
HC2. 11 women were invited for a Pap smear and 11
referred directly to colposcopy. Of the 11 women invited
for a Pap smear, only four (36 %) women attended. All
four women had a normal cytology. Of the 11 women
referred directly to colposcopy, one did not follow
the invitation. The total loss of follow-up was 36 %
(8/22). Among women referred to colposcopy, one was
Table 2 Adjusted relative risks for participation with self-
sampling in the brush device group in comparison to the lav-
age device group
RR 95 % CI
Totala 1.1 0,91–1,32
Age groupb
< =39 1.1 0,77–1,58
40–49 1.1 0,76–1,54
50–59 1.28 0,93–1,76
60–69 0.7 0,38–1,29
Mother tonguec
Finnish/Swedish 1.1 0,91–1,33
Other 0.95 0,28–3,20
Education leveld
Primary 1.59 0,65–3,91
Secondary 1.05 0,80–1,39
Tertiary 1.11 0,85–1,44
Marital statuse
Unmarried 1.17 0,84–1,64
Married/Widowed 1.08 0,85–1,38
Divorced 1.21 0,72–2,06
Municipality typef
Urban 1.15 0,89–1,50
Semi-urban 1.06 0,74–1,53
Rural 1.04 0,71–1,53
In the lavage group four women and in the brush-group eight women with
unknown marital status are excluded from the analysis. The women participat-
ing with a Pap smear after the self-sampling offer are not included as self-
sampling participants in this analysis
aAdjusted for age, mother tongue, education level, marital status and
municipality type
bAdjusted for mother tongue, education level, marital status and
municipality type
cAdjusted for age, education level, marital status and municipality type
dAdjusted for age, mother tongue, marital status and municipality type
eAdjusted for age, mother tongue, education level and municipality type
fAdjusted for age, mother tongue, education level and marital status
Fig. 2 The crude effects of reminder letter and self-sampling on
the attendance in the lavage device arm and in the brush device
arm. a Includes one woman in lavage device arm and six women in
the brush device arm that attended screening by Pap smear after
the self-sampling offer
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diagnosed with CIN3 (cervical intraepithelial neoplasia,
dysplasia gravis), five women had a benign finding such
as an inflammation or HPV-atypia and four women had
normal findings.
Discussion
The effects of self-sampling as a second reminder, i.e.,
after a primary invitation and a reminder letter, on total
screening attendance did not differ between the lavage
and the brush device. Participation with the brush device
was slightly higher (23.8 % vs 21.7 %; adjusted RR 1.1,
95 % CI 0.91–1.32), but no significant differences were
observed in total attendance after interventions (81.5;
95 % CI 79.5–81.5 vs 80.5 %; 95 % CI 80.5–82.5), or in
different socio-demographic groups. Further these self-
sampling devices were equally well accepted by the
women.
To our knowledge this study exploring the attendance
rates and acceptability of two different self-sampling de-
vices among non-attendees to routine screening was the
second of its kind. In the previous study from the
Netherlands, the self-sampling participation was slightly
but significantly higher with the brush device in com-
parison to the lavage device, the absolute difference be-
ing 2.7 %. No hypothesis was presented on the reasons
for the higher attendance with the brush device. In our
study the non-adjusted absolute difference between the
devices was similar, 2.1 %, but did not reach statistical
significance due to a smaller study cohort. The Dutch
further found no differences in the acceptability of the
two devices [16].
The achieved total participation rates in both groups
(80.5 % in the lavage group and 81.5 % in the brush
group) reached similar levels than in previous Finnish
studies with self-sampling used as a second reminder
[17]. The previously reported socio-demographic factors
related to lower participation rate, observed also in this
study, were young age (total participation rate 71 % in
this study), a mother tongue other than Finnish or
Swedish (71 %), a lower education level (71 %), having
never been married (75 %) and living in a rural munici-
pality (78 %) [6, 17]. In most of these hard-to-reach
groups, especially among women with a lower education
level, the brush device seemed to reach slightly higher
Fig. 3 Women’s experience on self-sampling with the lavage device and the brush device. Response frequencies based on the number of
completed responses to the sub-question, excluding those who answered “cannot say”. L = lavage device, B = brush device
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attendance rates by self-sampling, but the differences
were non-significant (Table 2). In the different mother
tongue groups, the difference in overall self-sampling
participation rates was not as marked as in previous
Finnish studies where as high as two-fold rates between
different mother tongue groups could be seen, [5, 6, 17],
and in the lavage group no difference between mother
tongue groups was seen (Table 1). This is encouraging,
and might be a reflection of self-sampling becoming
more familiar to the women to be screened.
HrHPV positivity rates did not differ significantly
between the devices, being 7.2 % with the lavage device
and 5.9 % with the brush device, but the overall positiv-
ity rate was lower than the approximately 12 % observed
in the previous Finnish self-sampling studies that also
used HC2 [6, 17]. Regardless of careful inspections,
no analysis-related reason for the lower hrHPV preva-
lence was found. Further no explanation was found by
Table 3 Self-sampling experiences of the under-screened self-
sampling participants with the lavage and the brush device
Lavage device Brush device
n % n %
Sample taking was easy
Agree 38 100.0 20 83.3
Neither agree nor disagree 0 0.0 2 8.3
Disagree 0 0.0 2 8.3
p-Value* 0.019
Sample taking was easier than I expected
Agree 36 100.0 18 75.0
Neither agree nor disagree 0 0.0 4 16.7
Disagree 0 0.0 2 8.3
p-Value 0.003
I believe that sample taking was succesful
Agree 31 91.2 18 78.3
Neither agree nor disagree 1 2.9 3 13.0
Disagree 2 5.9 2 8.7
p-Value 0.385
I felt insecure
Agree 31 91.2 18 78.3
Neither agree nor disagree 1 2.9 3 13.0
Disagree 2 5.9 2 8.7
p-Value 0.019
Sample taking was uncomfortable/unpleasant
Agree 31 88.6 18 72.0
Neither agree nor disagree 3 8.6 3 12.0
Disagree 1 2.9 4 16.0
p-Value 0.185
Sample taking was painful
Agree 33 100.0 21 84.0
Neither agree nor disagree 0 0.0 2 8.0
Disagree 0 0.0 2 8.0
p-Value 0.03
Sample taking was embarrasing/awkward
Agree 33 97.1 24 96.0
Neither agree nor disagree 1 2.9 0 0.0
Disagree 0 0.0 1 4.0
p-Value 0.672
I felt scared or anxious
Agree 34 100.0 22 88.0
Neither agree nor disagree 0 0.0 1 4.0
Disagree 0 0.0 2 8.0
p-Value 0.071
Table 3 Self-sampling experiences of the under-screened self-
sampling participants with the lavage and the brush device
(Continued)
I trust the test result
Agree 35 92.1 19 79.2
Neither agree nor disagree 3 7.9 3 12.5
Disagree 0 0.0 2 8.3
p-Value 0.158
Screening test is useful for me
Agree 36 94.7 24 92.3
Neither agree nor disagree 2 5.3 1 3.8
Disagree 0 0.0 1 3.8
p-Value 0.741
Testing can help prevent cancer
Agree 34 89.5 22 88.0
Neither agree nor disagree 3 7.9 2 8.0
Disagree 1 2.6 1 4.0
p-Value 1
Cancer or precancer can be detected with the test
Agree 35 92.1 25 96.2
Neither agree nor disagree 3 7.9 0 0.0
Disagree 0 0.0 1 3.8
p-Value 0.149
I would recommend test to a friend
Agree 37 100.0 24 92.3
Neither agree nor disagree 0 0.0 1 3.8
Disagree 0 0.0 1 3.8
p-Value 0.166
Response frequencies based on the number of completed responses to the
sub-question, excluding those who answered “cannot say”
*P values of Fisher’s exact test
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comparing the positivity rates of different municipalities,
i.e., regional results. The observed hrHPV prevalence
was in fact closer to the 8 % hrHPV prevalence by HC2
amongst women participating in the routine screening
[25]. This may be a result of simple coincidence due to
limited size of the study cohort or reflect to a low-risk
population taking part by self-sampling this particular
year. The sensitivity to detect CIN2+ lesions of HPV
testing on self-taken samples is around 80 % and is
somewhat lower compared to the clinician-taken sam-
ples when signal-based assays are used and thus further
attention to the analytical validity aspects with self-
sampling is required [26, 27].
The loss of follow-up, 36 % (8/22; 3/12 in the lavage
group and 5/10 in the brush group), was higher than
previously observed in Finnish studies [6, 17]. This was
due to the non-compliance of women referred to a Pap
smear (64 %) as the non-compliance rate to a colpos-
copy referral remained similar to previous experiences
(9 %). However, the actual fall out rate may not be as
high as reported: some women may have attended to
their follow-up visits outside the organized screening
program. In addition, three (14 %) of the hrHPV positive
women moved to a municipality not participating in this
study or abroad and thus their later health care records
were therefore no longer available. Previously, highest
compliance rates to follow-up Pap-smears in Finland,
79 %, were seen in a study that used pre-assigned ap-
pointment times in the invitations [6], making this the
recommended invitational protocol if Pap-smear triage
after self-sampling is used in the future.
Opportunistic Pap testing is extensive in Finland: 60 %
of the Pap test taken for screening purposes are taken
outside the organized program and the overall screening
coverage in Finland is nearly 90 % when both organized
and opportunistic tests are taken into account [28]. Op-
portunistic tests are not recorded in common databases
in Finland, and were thus not available for those who
did not respond to the questionnaire. Thus, even though
the reminder letter and self-sampling increased the
screening attendance, the exact effects on the overall
screening coverage could not be calculated among all in-
vited - this is a clear limitation of the study. The effect
on the screening coverage remained smaller than the in-
crease in the attendance, as only 20 % of the self-
sampling participants were under-screened.
The response rate to the questionnaire was high in
both groups, the demographic profile corresponded to
the study cohort as a whole and the results thus give a
reliable picture on previously non-attending women’s
views on self-sampling. Self-sampling was regarded as
easy with both devices by almost all participants who an-
swered the question. Negative experiences (insecurity,
discomfort, pain, embarrassment and fear) were reported
rarely, but slightly more often with the brush device
(Fig. 3). These minor differences in the self-sampling ex-
periences between the sampler devices were however
statistically non-significant and overall they did not seem
to affect the willingness to participate with the brush de-
vice, as the self-sampling participation rate was higher in
the brush device group. However, in the limited popula-
tion of previously under-screened self-sampling partici-
pants (n = 67), self-sampling was more often regarded easy
with the lavage device and some negative feelings were
more often reported with the brush device (Table 3). This
may reflect better acceptability of the lavage sampler in
this high risk population, but the small number of obser-
vations clearly limits the wider generalization.
The previously observed higher prevalence of insecur-
ity, fear and anxiety during sample taking amongst
women with mother tongue other than Finnish or Swed-
ish [15] was not observed in this study. None of the
women in this language group reported having experi-
enced fear or anxiety. Insecurity was reported by 33 %
(2/6) of the lavage device participants but by none of the
brush device participants. Amongst Finnish or Swedish
speaking women insecurity was reported by 20 % (29/
142) in the lavage group and 24 % (36/149) in the brush
group. Mistrust on one’s ability to take the self-sample
correctly and/or in the test result, often expressed as a
barrier to self-sampling in previous studies [21–23, 29,
30], was not observed in this study. 93 % of women in
both groups reported having felt confident about taking
the sample correctly and 90 % of women in the lavage
group and 85 % in the brush group stated that they trust
the test result. Further, the mistrust in one’s ability to
collect the sample, was rarely expressed as a reason to
decline the self-sampling after receiving the sampler de-
vice, but slightly more often in the brush-group (17 %;
4/24 vs 8 %;2/25).
This study was conducted in a diverse set of Finnish
municipalities where major invitational factors influen-
cing the participation rates, personal invitations with
pre-assigned appointment times and reminder letters to
non-attendees, are already used. Previous self-sampling
experiences in Finland were obtained with a lavage sam-
pler that is no longer available in the market. Thus the
current results of no significant differences between the
sampler devices in overall attendance rate or user com-
fort allow for wider generalization of the previous results
in further planning of invitation protocols. As an essen-
tial aspect of hrHPV-testing on self-taken samples is the
heterogeneity between hrHPV-testing methods [26, 27],
the choice of a self-sampling method for the Finnish
program can thus be based on a clinically validated and
cost-effective pair of a sampling device and a testing
assay without the fear of losing women due to a less ac-
ceptable device.
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